We have observed
32 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 14, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Method for the treatment of lysozomal lipid storage diseases
Method for determining hepatotoxicity of a compound.
Method for determining the risk of developing severe dyspnea after radiation therapy
Composition having a beneficial effect on the cardiovascular system, comprising monacolin K, lycopene and vitamin D3
AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY
Method for predicting the skin sensitizing activity of a compound.
IN VITRO METHOD FOR PREDICTING DISEASE OUTCOME IN STAGE II COLORECTAL CANCER
METHOD FOR THE IN VITRO MATURATION OF DENDRITIC CELLS
METHOD FOR LOADING OF DENDRITIC CELLS WITH CLASS I ANTIGENS
CONTRAST AGENT AND ITS USE FOR IMAGING
THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
METHOD FOR SAVING ENERGY IN PAPER PRODUCTION
METHOD FOR IMPROVING THE FERMENTABLE SUGAR YIELD FROM LIGNOCELLULOSIC SUBSTRATES
BLASTOID, CELL LINE BASED ARTIFICIAL BLASTOCYST
A system for stabilization of at least a portion of a spinal column as well as an anchor member suitable for such a system
METHOD FOR DETERMINING THE RISK OF DEVELOPING RADIATION-INDUCED TOXICITY AFTER EXPOSURE TO RADIATION
COMPOSITION HAVING A BENEFICIAL EFFECT ON THE CARDIOVASCULAR SYSTEM, COMPRISING MONACOLIN K, LYCOPENE AND VITAMIN D3
TREATMENT OF COGNITIVE IMPAIRMENT WITH COMBINATION THERAPY
TREATMENT OF COGNITIVE IMPAIRMENT WITH PDE4 INHIBITOR
METHOD FOR THE TREATMENT OF DIABETES MELLITUS
METHOD FOR REDUCING THE INFLAMMATORY ACTIVITY OF A STEM CELL TRANSPLANT AND USE THEREOF
METHOD FOR RESTORING IMMUNE TOLERANCE IN VIVO
ANTI-INFLAMMATORY AGENTS DIRECTED AGAINST CITRULLINATED EPITOPES
NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES AGAINST HEPATITIS B VIRUS SURFACE ANTIGEN
METHOD FOR DETERMINING THE LEVEL OF HYPOXIA IN A TUMOR
LACCASE VARIANTS WITH IMPROVED PROPERTIES
MICRORNAS FOR THE TREATMENT OF HEART DISEASES
METHOD FOR THE SEROLOGICAL DIAGNOSIS OF RHEUMATOID ARTHRITIS.
IN VITRO METHOD FOR DETERMINING IMMUNOTOXICITY OF A COMPOUND
METHOD FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS